Literature DB >> 21435106

Color vision in Parkinson's disease and essential tremor.

Y-S Oh1, J-S Kim, S-W Chung, I-U Song, Y-D Kim, Y-I Kim, K-S Lee.   

Abstract

BACKGROUND AND
PURPOSE: Decreased visual function is one of the non-motor dysfunctions of Parkinson's disease (PD). Recent evidences suggest that essential tremor (ET) is not 'pure' motor disorder and there is growing evidence that this disease is a multiple-system disorder. In some cases, it is difficult to differentiate ET from PD. In addition, there is considerable controversy regarding the relationship between PD and ET. The objective of this study was to compare color discrimination dysfunction amongst patients with PD and ET and to investigate the clinical relevance.
METHODS: Case-control comparisons of 54 patients with PD, 36 patients with ET, and 34 age-matched controls were performed. All cases underwent Farnsworth-Munsell 100 Hue test (FMT) and clinical assessments on medication. In addition, the association between color vision abnormalities and motor handicaps was investigated.
RESULTS: There were significant differences in the total error scores (TES) of the FMT amongst the three groups; patients with the PD had higher TES than the patients with ET and the controls after adjustments for age. In addition, the motor symptom severity in PD correlated with the FMT abnormalities, especially with regard to the axial symptoms.
CONCLUSION: The results of this study suggest that color vision abnormalities may be one of the non-motor clinical characteristics of PD-related dysfunction in contrast to ET. In addition, the severity of axial motor symptoms was closely related to visual dysfunction. Confirmation of these findings as well as the mechanisms underlying these results requires further study.
© 2010 The Author(s). European Journal of Neurology © 2010 EFNS.

Entities:  

Mesh:

Year:  2010        PMID: 21435106     DOI: 10.1111/j.1468-1331.2010.03206.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  13 in total

1.  Color vision: a study of essential tremor cases versus normal controls.

Authors:  E D Louis; M Gerbin; A S Viner
Journal:  Eur J Neurol       Date:  2012-03-15       Impact factor: 6.089

2.  α-Synuclein in the colon and premotor markers of Parkinson disease in neurologically normal subjects.

Authors:  Joong-Seok Kim; In-Seok Park; Hyung-Eun Park; Su-Young Kim; Jung A Yun; Chan Kwon Jung; Hye-Young Sung; Jin-Kwon Lee; Won-Kyung Kang
Journal:  Neurol Sci       Date:  2016-11-01       Impact factor: 3.307

Review 3.  Multimodal brain and retinal imaging of dopaminergic degeneration in Parkinson disease.

Authors:  Jee-Young Lee; Antonio Martin-Bastida; Ane Murueta-Goyena; Iñigo Gabilondo; Nicolás Cuenca; Paola Piccini; Beomseok Jeon
Journal:  Nat Rev Neurol       Date:  2022-02-17       Impact factor: 44.711

4.  Visual dysfunction in patients with Parkinson's disease and essential tremor.

Authors:  Ivanka Štenc Bradvica; Mario Bradvica; Suzana Matić; Patricia Reisz-Majić
Journal:  Neurol Sci       Date:  2014-08-28       Impact factor: 3.307

Review 5.  [The eye as a window to the pathophysiology in Parkinson's syndromes].

Authors:  J Kassubek; A Danek; K Del Tredici-Braak; M W Greenlee; E H Pinkhardt
Journal:  Nervenarzt       Date:  2013-08       Impact factor: 1.214

6.  The Non-motor Features of Essential Tremor: A Primary Disease Feature or Just a Secondary Phenomenon?

Authors:  Ketan Jhunjhunwala; Pramod K Pal
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2014-08-05

7.  Visual dysfunction and its correlation with retinal changes in patients with Parkinson's disease: an observational cross-sectional study.

Authors:  V Polo; M Satue; M J Rodrigo; S Otin; R Alarcia; M P Bambo; M I Fuertes; J M Larrosa; L E Pablo; E Garcia-Martin
Journal:  BMJ Open       Date:  2016-05-06       Impact factor: 2.692

Review 8.  Optical Coherence Tomography as a Biomarker for Diagnosis, Progression, and Prognosis of Neurodegenerative Diseases.

Authors:  Maria Satue; Javier Obis; Maria J Rodrigo; Sofia Otin; Maria I Fuertes; Elisa Vilades; Hector Gracia; Jose R Ara; Raquel Alarcia; Vicente Polo; Jose M Larrosa; Luis E Pablo; Elena Garcia-Martin
Journal:  J Ophthalmol       Date:  2016-10-20       Impact factor: 1.909

Review 9.  Visual dysfunction in Parkinson's disease.

Authors:  Rimona S Weil; Anette E Schrag; Jason D Warren; Sebastian J Crutch; Andrew J Lees; Huw R Morris
Journal:  Brain       Date:  2016-11-01       Impact factor: 15.255

Review 10.  Oculo-Visual Dysfunction in Parkinson's Disease.

Authors:  R A Armstrong
Journal:  J Parkinsons Dis       Date:  2015       Impact factor: 5.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.